80 related articles for article (PubMed ID: 19660867)
1. Haeme oxygenase-1 overexpression via nAChRs and the transcription factor Nrf2 has antinociceptive effects in the formalin test.
Egea J; Rosa AO; Lorrio S; del Barrio L; Cuadrado A; López MG
Pain; 2009 Nov; 146(1-2):75-83. PubMed ID: 19660867
[TBL] [Abstract][Full Text] [Related]
2. Nrf2-mediated haeme oxygenase-1 up-regulation induced by cobalt protoporphyrin has antinociceptive effects against inflammatory pain in the formalin test in mice.
Rosa AO; Egea J; Lorrio S; Rojo AI; Cuadrado A; López MG
Pain; 2008 Jul; 137(2):332-339. PubMed ID: 17964723
[TBL] [Abstract][Full Text] [Related]
3. The dorsal raphe nucleus as a site of action of the antinociceptive and behavioral effects of the alpha4 nicotinic receptor agonist epibatidine.
Cucchiaro G; Chaijale N; Commons KG
J Pharmacol Exp Ther; 2005 Apr; 313(1):389-94. PubMed ID: 15608080
[TBL] [Abstract][Full Text] [Related]
4. Enhanced antinociception by nicotinic receptor agonist epibatidine and adrenal medullary transplants in the spinal subarachnoid space.
Caban AJ; Hama AT; Lee JW; Sagen J
Neuropharmacology; 2004 Jul; 47(1):106-16. PubMed ID: 15165838
[TBL] [Abstract][Full Text] [Related]
5. Nicotinic receptor activation by epibatidine induces heme oxygenase-1 and protects chromaffin cells against oxidative stress.
Egea J; Rosa AO; Cuadrado A; García AG; López MG
J Neurochem; 2007 Sep; 102(6):1842-1852. PubMed ID: 17540012
[TBL] [Abstract][Full Text] [Related]
6. The locus coeruleus nucleus as a site of action of the antinociceptive and behavioral effects of the nicotinic receptor agonist, epibatidine.
Cucchiaro G; Chaijale N; Commons KG
Neuropharmacology; 2006 Jun; 50(7):769-76. PubMed ID: 16460769
[TBL] [Abstract][Full Text] [Related]
7. A-85380 and epibatidine each interact with disparate spinal nicotinic receptor subtypes to achieve analgesia and nociception.
Khan IM; Stanislaus S; Zhang L; Taylor P; Yaksh TL
J Pharmacol Exp Ther; 2001 Apr; 297(1):230-9. PubMed ID: 11259549
[TBL] [Abstract][Full Text] [Related]
8. The role of nicotinic acetylcholine and opioid systems of the ventral orbital cortex in modulation of formalin-induced orofacial pain in rats.
Yousofizadeh S; Tamaddonfard E; Farshid AA
Eur J Pharmacol; 2015 Jul; 758():147-52. PubMed ID: 25864612
[TBL] [Abstract][Full Text] [Related]
9. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Anderson DJ; Campbell JE; Piattoni-Kaplan M; McKenna DG; Wasicak JT; Holladay MW; Williams M; Arneric SP
J Pharmacol Exp Ther; 1998 May; 285(2):777-86. PubMed ID: 9580626
[TBL] [Abstract][Full Text] [Related]
10. Antinociceptive effects of novel epibatidine analogs through activation of α4β2 nicotinic receptors.
Li W; Cai J; Wang BH; Huang L; Fan J; Wang Y
Sci China Life Sci; 2018 Jun; 61(6):688-695. PubMed ID: 29435707
[TBL] [Abstract][Full Text] [Related]
11. Tolerance to the antinociceptive effect of epibatidine after acute and chronic administration in mice.
Damaj MI; Martin BR
Eur J Pharmacol; 1996 Apr; 300(1-2):51-7. PubMed ID: 8741164
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, nicotinic acetylcholine receptor binding, antinociceptive and seizure properties of methyllycaconitine analogs.
Ivy Carroll F; Ma W; Navarro HA; Abraham P; Wolckenhauer SA; Damaj MI; Martin BR
Bioorg Med Chem; 2007 Jan; 15(2):678-85. PubMed ID: 17098430
[TBL] [Abstract][Full Text] [Related]
13. The Induction of Heme Oxygenase 1 Decreases Painful Diabetic Neuropathy and Enhances the Antinociceptive Effects of Morphine in Diabetic Mice.
Castany S; Carcolé M; Leánez S; Pol O
PLoS One; 2016; 11(1):e0146427. PubMed ID: 26730587
[TBL] [Abstract][Full Text] [Related]
14. Antinociceptive and toxic effects of (+)-epibatidine oxalate attributable to nicotinic agonist activity.
Rupniak NM; Patel S; Marwood R; Webb J; Traynor JR; Elliott J; Freedman SB; Fletcher SR; Hill RG
Br J Pharmacol; 1994 Dec; 113(4):1487-93. PubMed ID: 7889306
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetic variability in neuronal nicotinic receptor-mediated antinociception.
Flores CM; Wilson SG; Mogil JS
Pharmacogenetics; 1999 Oct; 9(5):619-25. PubMed ID: 10591542
[TBL] [Abstract][Full Text] [Related]
16. Treatment with a heme oxygenase 1 inducer enhances the antinociceptive effects of µ-opioid, δ-opioid, and cannabinoid 2 receptors during inflammatory pain.
Carcolé M; Castany S; Leánez S; Pol O
J Pharmacol Exp Ther; 2014 Oct; 351(1):224-32. PubMed ID: 25204546
[TBL] [Abstract][Full Text] [Related]
17. Activation of the cholinergic anti-inflammatory pathway by nicotine attenuates hepatic ischemia/reperfusion injury via heme oxygenase-1 induction.
Park J; Kang JW; Lee SM
Eur J Pharmacol; 2013 May; 707(1-3):61-70. PubMed ID: 23535606
[TBL] [Abstract][Full Text] [Related]
18. Differences between the antinociceptive effects of the cholinergic channel activators A-85380 and (+/-)-epibatidine in rats.
Curzon P; Nikkel AL; Bannon AW; Arneric SP; Decker MW
J Pharmacol Exp Ther; 1998 Dec; 287(3):847-53. PubMed ID: 9864263
[TBL] [Abstract][Full Text] [Related]
19. The antinociceptive effect of intrathecal administration of epibatidine with clonidine or neostigmine in the formalin test in rats.
Hama AT; Lloyd GK; Menzaghi F
Pain; 2001 Mar; 91(1-2):131-8. PubMed ID: 11240085
[TBL] [Abstract][Full Text] [Related]
20. The effect of formalin pretreatment on nicotine-induced antinociceptive effect: the role of mu-opioid receptor in the hippocampus.
Kwon MS; Seo YJ; Choi SM; Lee JK; Jung JS; Park SH; Suh HW
Neuroscience; 2008 Jun; 154(2):415-23. PubMed ID: 18456411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
